Search results
Results from the WOW.Com Content Network
Besides its use in medicine, tapinarof is a naturally occurring compound found in bacterial symbionts of nematodes which has antibiotic properties. [2] [3] The medication acts as an aryl hydrocarbon receptor agonist. [1] [4] Tapinarof was approved for medical use in the United States in May 2022.
Asciminib was approved for medical use in the European Union in August 2022. [6] [19] The US Food and Drug Administration (FDA) granted the application for asciminib priority review, fast track, orphan drug, and breakthrough therapy designations. [7] [20] [21] [22]
Because dalbavancin has demonstrated efficacy against MRSA and other microorganisms to treat serious or life-threatening infections, it was the first drug approved as a Qualified Infectious Disease Product under the Generating Antibiotic Incentives Now (GAIN) act, which is part of the FDA Safety and Innovation Act. [17]
The antibiotic, which would be the first new gonorrhea treatment approved in decades, could make it to market by 2025. The World Health Organization estimates that globally there are more than 82 ...
The approval of Appili's drug could help ease the metronidazole shortage in the U.S., especially for patients in hospitalized settings and those with severe i Canada's Appili gets US FDA approval ...
Brilacidin (formerly PMX-30063 [2]), an investigational new drug, is a polymer-based antibiotic currently in human clinical trials, and represents a new class of antibiotics called host defense protein mimetics, or HDP-mimetics, which are non-peptide synthetic small molecules modeled after host defense peptides (HDPs).
Omidenepag was approved for medical use in Japan in 2018, [3] and in the United States in September 2022. [2] [4] ... Drug Information Portal. U.S. National Library ...
The FDA’s recent ban on Red Dye No. 3, set to take effect by 2027 for foods and 2028 for drugs, marks a significant step in addressing safety concerns over artificial food dyes in the U.S. food ...